Overall, the results from these 2 independent cohorts and IBD biopsies suggest that IgG anti-MAA displayed a better discriminatory performance over IgM and IgA anti-MAA antibodies in identifying UC and differentiating from CD. The gene discussed is CD40LG; the disease is irritable bowel syndrome.